Table 10.
Mirabegron 50 mg | Mirabegron 100 mg | Tolterodine 4mg | |
---|---|---|---|
Change in number of micturitions in 24 hours from baseline | –1.27 | –1.41 | –1.39 |
Change in number of incontinence episodes from baseline | –1.01 | –1.24 | –1.26 |
Change in mean volume voided/micturition (ml) | +17.5 | +21.5 | +18.1 |
Percentage of responders with >50% decrease in mean number incontinence episode per 24 hours | 63.7% | 66.3% | 66.8% |
Percentage of responders for zero incontinence | 43.4% | 45.8% | 45.1% |
Discontinuation due to lack of efficacy | 3.6% | 5.5% |